Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10213525 | International Journal of Cardiology | 2018 | 6 Pages |
Abstract
AHF patients, particularly those with lower severity, may benefit from rapid administration of IV furosemide in the ED. This suggests that a key determinant of hospital visit duration in this low-risk cohort is decongestion, which occurs sooner when IV therapy is begun early in the ED stay regardless of serum creatinine.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael J. Ward, Sean P. Collins, Dandan Liu, Craig M. Froehle,